Profiles

Keywords
Last Name
Institution
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Annabelle Volgman and Kim Williams.

 
Connection Strength
  
 
 
0.838
  
  1. Gomez JMD, Du-Fay-de-Lavallaz JM, Fugar S, Sarau A, Simmons JA, Clark B, Sanghani RM, Aggarwal NT, Williams KA, Doukky R, Volgman AS. Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt). 2021 05; 30(5):646-653.
    View in: PubMed
    Score: 0.208
  2. Moseley A, Doukky R, Williams KA, Jaffer AK, Volgman AS. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation. J Womens Health (Larchmt). 2017 03; 26(3):214-221.
    View in: PubMed
    Score: 0.153
  3. Costello BT, Silverman ER, Doukky R, Braun LT, Aggarwal NT, Deng Y, Li Y, Lundberg G, Williams KA, Volgman AS. Lipoprotein(a) and Increased Cardiovascular Risk in Women. Clin Cardiol. 2016 Feb; 39(2):96-102.
    View in: PubMed
    Score: 0.145
  4. Kerolos MM, Ruge M, Gill A, Planek MI, Volgman AS, Du-Fay-De-Lavallaz JM, Gomez JMD, Suboc TM, Williams KA, Abusin S. Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease. Am Heart J Plus. 2022 Aug; 20:100189.
    View in: PubMed
    Score: 0.057
  5. Luo S, Vasbinder A, Du-Fay-de-Lavallaz JM, Gomez JMD, Suboc T, Anderson E, Tekumulla A, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O'Hayer P, Catalan T, Blakely P, Launius C, Amadi KM, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Altintas I, Eugen-Olsen J, Williams KA, Volgman AS, Reiser J, Hayek SS. Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.
    View in: PubMed
    Score: 0.057
  6. Rahman A, Ruge M, Hlepas A, Nair G, Gomez J, du Fay de Lavallaz J, Fugar S, Jahan N, Volgman AS, Williams KA, Rao A, Marinescu K, Suboc T. Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients. Am Heart J Plus. 2022 Feb; 14:100134.
    View in: PubMed
    Score: 0.056
  7. Patel P, Ruge M, Gomez JMD, du Fay de Lavallaz J, Rao A, Williams KA, Volgman AS, Costanzo MRR, Suboc T, Marinescu K. Prognostic value of H2FPEF score in COVID-19. Am Heart J Plus. 2022 Jan; 13:100111.
    View in: PubMed
    Score: 0.055
  8. Planek MIC, Ruge M, Du Fay de Lavallaz JM, Kyung SB, Gomez JMD, Suboc TM, Williams KA, Volgman AS, Simmons JA, Rao AK. Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes. Am Heart J Plus. 2021 Nov; 11:100052.
    View in: PubMed
    Score: 0.054
  9. Ruge M, Gomez JMD, du Fay de Lavallaz J, Hlepas A, Rahman A, Patel P, Lavani P, Nair GG, Jahan N, Simmons JA, Rao AK, Williams KA, Volgman AS, Marinescu K, Suboc T. The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.